Hideki Tokaibayashi
Director/Board Member bei TELLA, INC.
Profil
Hideki Tokaibayashi is currently an Outside Director at tella, Inc. and a Representative Director at GranCharite Co. Ltd.
He was previously an Independent Outside Director at Remixpoint, Inc. from 2020 to 2022.
Aktive Positionen von Hideki Tokaibayashi
| Unternehmen | Position | Beginn |
|---|---|---|
| TELLA, INC. | Director/Board Member | 01.03.2021 |
| GranCharite Co. Ltd. | Director/Board Member | 01.11.2017 |
Ehemalige bekannte Positionen von Hideki Tokaibayashi
| Unternehmen | Position | Ende |
|---|---|---|
| REMIXPOINT, INC. | Director/Board Member | 28.06.2022 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| REMIXPOINT, INC. | Technology Services |
| Private Unternehmen | 2 |
|---|---|
| GranCharite Co. Ltd. | |
tella, Inc.
 tella, Inc. BiotechnologyHealth Technology tella, Inc. engages in research and development of dendritic cell (DC) vaccine therapy. It operates through the following segments: Cell Medicine, Medical Support, and Pharmaceuticals. The Cell Medicine segment provides cancer treatment technology and know-hows centered on dendritic cell vaccine therapy. The Medical Support segment manages contact research organization (CRO) business and offers genetic testing services. The Pharmaceuticals segment deals with the development of dendritic cell vaccine as a cancer treatment. The company was founded by Yuichiro Yazaki on June 24, 2004 and is headquartered in Tokyo, Japan. | Health Technology |
